Mutagenicity of benzo[a]pyrene and dibenzopyrenes in the Salmonella typhimurium TM677 and the MCL-5 human cell forward mutation assays

https://doi.org/10.1016/0165-1218(95)90085-3Get rights and content

Abstract

The mutagenicity of beno[a]pyrene (B[a]P), dibenzo[ae]pyrene (DB[ae]P), dibenzo[ah]pyrene (DB[ah]P), dibenzo[ai]pyrene (DB[ai]P) and dibenzo[al]pyrene (DB[ai]P was measured in quantitative forward mutation assays with bacteria (Salmonella typhimuriu TM677) and a metabolically copettent cell line derived from human B-lymphoblastoid cells (MCL-5) that contained activity for five cytochrome P450s and microsomal epoxide hydrolase found in human liver.

DB[al]P and B[a]P, both potent animal carcinogens, were the most mutagenic substances in both assays. DB[al]P was nearly 50-fold more potent than B[a]P in human cells. but only 60% more mutagenic in Salmonella. The carcinogenic isomer DB[ah]P, though nonmutagenic in bacteria, was active in human cells. The following mutagenic potency series, expressed as the minimum detectable mutagen concentration (MDMC) in nmol/ml, was obtained with Salmonella in the presence of rat liver postmitochondrial supernatant (PMS): DB[al]P(3.7), B[a]P (5.8), DBae]P (6.9), DB[ai]P (14.9), DB[ah]P (> 100). None of the compounds were mutagenic in the absence of PMS. In human MCL-5 cells the potency series was: DB[al]P (3.1 × 10−4), B[a]P (1.5 × 10−2), DB[ae]P (2.5 × 10−2), DB[ah]P (0.5), DB[ai]P (3.2). The human cell assay thus exhibited over a 10 000-fold range between the most mutagenic and least mutagenic compound, whereas in the bacterial assay there was only a corresponding four-fold difference if the nonmutagenic DB[ah]P was excluded. The results were discussed in terms of their concordance with animal carcinogenicity studies.

References (30)

  • E.L. Cavalieri et al.

    Comparative dose-response tumorigenicity studies of dibenzo[a,l]pyrene versus 7,12-dimethylbenz[a]anthracene, benzo[a]pyrene and two dibenzo[a,l]pyrene dihydrodiols in mouse skin and rat mammary gland

    Carcinogenesis

    (1991)
  • E.L. Cavalieri et al.

    Tumor-initiating activity in mouse skin and carcinogenicity in rat mammary gland of dibenzo[a]pyrenes: the very potent environmental carcinogen dibenzo[a,l]pyrene

    J. Cancer Res. Clin. Oncol.

    (1989)
  • R.L. Chang et al.

    Tumorigenicity of bay-region diol-epoxides and other benzo-ring derivatives of dibenzo(a,h)pyrene and dibenzo(a,i)pyrene on mouse skin and in newborn mice

    Cancer Res.

    (1982)
  • C.L. Crespi et al.

    A metabolically competent human cell line expressing five cDNAs encoding procarcinogen-activating enzymes: application to mutagenicity testing

    Chem. Res. Toxicol.

    (1991)
  • P.D. Devanesan et al.

    Metabolism and mutagenicity of dibenzo[a,e]pyrene and the very potent environmental carcinogen dibenzo[a,l]pyrene

    Chem. Res. Toxicol.

    (1990)
  • Cited by (43)

    • A look beyond the priority: A systematic review of the genotoxic, mutagenic, and carcinogenic endpoints of non-priority PAHs

      2021, Environmental Pollution
      Citation Excerpt :

      Thirty-four studies have shown the potential of Db[al]P in genotoxicity events, studied using different approaches, such as computational prediction (Mersch-Sundermann et al., 1992a; 1992c), generation of adducts (Binková et al., 2000; Buters et al., 2002; Cavalieri et al., 2005; Chen et al., 2012; DeMarini et al., 2011; Dreij et al., 2004, 2005; Harper et al., 2015; King et al., 1999; Lagerqvist et al., 2008; Luch et al., 1999; Mahadevan et al., 2005, 2006; Melendez-Colon et al., 1999; Nakatsuru et al., 2004; Nesnow, 1997; Prahalad, 1997; Siddens et al., 2012; Todorovic et al., 2005; Topinka et al., 2008; Wohak et al., 2016; Yoon et al., 2004; Zhang et al., 2011, 2014), comet assay (Mourón et al., 2006; Niziolek-Kierecka et al., 2012), phosphorylation of H2AX (ɣH2AX) (Audebert et al., 2012; Kucab et al., 2019; Niziolek-Kierecka et al., 2012; Zheng et al., 2019), chromosomal damage (Meschini et al., 2010; Mourón et al., 2006) in different experimental models, such as cell culture or mice and rats, and using the chromotest assay in E. coli in the presence of S9 (Mersch-Sundermann et al., 1992b). Db[al]P mutagenicity was positive in all ten studies in both prokaryotic (Salmonella TA98, TA100, TA104, and TM677 strains) (Busby et al., 1995; DeMarini et al., 2011; Devanesan et al., 1990) and eukaryotic (HPRT and tk loci) (Busby et al., 1995; Durant et al., 1996; Kushman et al., 2007; Lagerqvist et al., 2008) models, as well as in transgenic mice with germ cell mutations (Chen et al., 2013; Guttenplan et al., 2012; Leavitt et al., 2008). Db[al]P induced tumor formation (11 studies) in different strains of mice and rats (Amin et al., 1995; Buters et al., 2002; Cavalieri et al., 1989, 1991; Chen et al., 2012, 2013; LaVoie et al., 1993; Madeen et al., 2017; Prahalad, 1997; Shorey et al., 2012; Siddens et al., 2012) (Fig. 6L, Table S14).

    • Cancer chemoprevention by dietary chlorophylls: A 12,000-animal dose-dose matrix biomarker and tumor study

      2012, Food and Chemical Toxicology
      Citation Excerpt :

      The polycyclic aromatic hydrocarbon dibenzo(def,p)chrysene (DBC), formerly known as dibenzo(a,l)pyrene or DBP, can be readily detected on particulate matter from wood charcoal, coal, and fuel–oil combustion (Deraat et al., 1987; Mumford et al., 1987, 1995) in soil and sediment samples (Kozin et al., 1995), in vehicle exhaust condensate (Seidel et al., 2004), and in tobacco smoke condensate (Snook et al., 1977; Hoffmann and Hoffmann, 1998). DBC displays strong in vitro mutagenicity in bacterial and animal cell assays (Busby et al., 1995; Durant et al., 1999), forms multiple DNA adducts in vitro and in vivo (Mahadevan et al., 2005), and may act in vivo through promotional as well as tumor initiation mechanisms (Baird et al., 2005). Comparative studies in rodent models have demonstrated DBC to be the most carcinogenic polycyclic aromatic hydrocarbon tested to date, significantly exceeding the potencies of the well-known carcinogens benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene (Cavalieri et al., 1989, 1991; Higginbotham et al., 1993; LaVoie et al., 1993).

    • Association between mutation spectra and stable and unstable DNA adduct profiles in Salmonella for benzo[a]pyrene and dibenzo[a,l]pyrene

      2011, Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
      Citation Excerpt :

      Although DBP did not induce a significant increase in unstable DNA adducts relative to the control (P = 0.78), BP did (P = 0.03). As noted in Section 1, DBP is more carcinogenic in rodents, more mutagenic in forward-mutation assays, and is a more potent DNA-damaging agent than BP [11–20]. However, the relative mutagenic potencies of these PAHs vary in bacterial reverse-mutation assays depending on the strain [21] (Table 2).

    • Characterization of naphtho[1,2-a]pyrene and naphtho[1,2-e]pyrene DNA adducts in C3H10T1/2 fibroblasts

      2007, Cancer Letters
      Citation Excerpt :

      Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous anthropomorphic environmental pollutants that represent a large class of carcinogenic chemicals. Dibenzo[a,l]pyrene (DB[a,l]P) is a hexacyclic PAH containing a pyrene moiety and a fjord-region that possesses high mutagenic and carcinogenic activities (Fig. 1) [1–5]. DB[a,l]P is the most potent PAH tested and is more potent than benzo[a]pyrene (B[a]P) in mutagenicity and carcinogenicity assays [1–5].

    View all citing articles on Scopus
    View full text